Peter Sever
Peter Sever
Professor of Clinical Pharmacology, Imperial College London
Email verificata su imperial.ac.uk
Titolo
Citata da
Citata da
Anno
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
11354*2017
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, LE Holland, C Reith, N Bhala, R Peto, ...
Lancet (London, England) 376 (9753), 1670-1681, 2010
5681*2010
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavianá…
PS Sever, B Dahl÷f, NR Poulter, H Wedel, G Beevers, M Caulfield, ...
The Lancet 361 (9364), 1149-1158, 2003
51222003
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in theá…
B Dahl÷f, PS Sever, NR Poulter, H Wedel, DG Beevers, M Caulfield, ...
The Lancet 366 (9489), 895-906, 2005
41062005
Treatment of hypertension in patients 80 years of age or older
NS Beckett, R Peters, AE Fletcher, JA Staessen, L Liu, D Dumitrascu, ...
New England Journal of Medicine 358 (18), 1887-1898, 2008
38522008
Evolocumab and clinical outcomes in patients with cardiovascular disease
MS Sabatine, RP Giugliano, AC Keech, N Honarpour, SD Wiviott, ...
New England Journal of Medicine 376 (18), 1713-1722, 2017
30132017
Genetic studies of body mass index yield new insights for obesity biology
AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ...
Nature 518 (7538), 197-206, 2015
28232015
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
Blood Pressure Lowering Treatment Trialists' Collaboration
The Lancet 362 (9395), 1527-1535, 2003
27632003
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
PM Rothwell, SC Howard, E Dolan, E O'Brien, JE Dobson, B Dahl÷f, ...
The Lancet 375 (9718), 895-905, 2010
18942010
Defining the role of common variation in the genomic and biological architecture of adult human height
AR Wood, T Esko, J Yang, S Vedantam, TH Pers, S Gustafsson, AY Chu, ...
Nature genetics 46 (11), 1173-1186, 2014
15342014
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
B Williams, NR Poulter, MJ Brown, M Davis, GT McInnes, JF Potter, ...
Journal of human hypertension 18 (3), 139-185, 2004
12602004
Interpretation of the evidence for the efficacy and safety of statin therapy
R Collins, C Reith, J Emberson, J Armitage, C Baigent, L Blackwell, ...
The Lancet 388 (10059), 2532-2561, 2016
10892016
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary
B Williams, NR Poulter, MJ Brown, M Davis, GT McInnes, JF Potter, ...
Bmj 328 (7440), 634-640, 2004
9242004
Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke
PM Rothwell, SC Howard, E Dolan, E O'Brien, JE Dobson, B Dahl÷f, ...
The Lancet Neurology 9 (5), 469-480, 2010
7112010
Effect of spironolactone on blood pressure in subjects with resistant hypertension
N Chapman, J Dobson, S Wilson, B Dahlof, PS Sever, H Wedel, ...
hypertension 49 (4), 839-845, 2007
7082007
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
B Williams, TM MacDonald, S Morant, DJ Webb, P Sever, G McInnes, ...
The Lancet 386 (10008), 2059-2068, 2015
6502015
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65 229 participants
KK Ray, SRK Seshasai, S Erqou, P Sever, JW Jukema, I Ford, N Sattar
Archives of internal medicine 170 (12), 1024-1031, 2010
6242010
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
CT Trialists
The Lancet 371 (9607), 117-125, 2008
5222008
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Armá…
NR Poulter, H Wedel, B Dahl÷f, PS Sever, DG Beevers, M Caulfield, ...
The Lancet 366 (9489), 907-913, 2005
5122005
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ...
The Lancet 385 (9965), 351-361, 2015
5072015
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20